Apnimed, Inc. Asset Turnover Ratio (APMD), as of second quarter 2026, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Apnimed, Inc.  (Nasdaq: APMD)
 

Apnimed Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Due to the increase in investments during the second quarter 2026, Apnimed's asset turnover ratio sequentially decreased to 0.44 in the second quarter (Jun 30 2026), but remained above the company's average. For every Dollar on the Balance Sheet, Apnimed, Inc. realized $0.44 in annual sales.

Within sector Apnimed, Inc. achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

APMD Asset Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
II. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
II. Quarter
Y / Y Asset Change - - - - -
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.44 - - - -
APMD's Total Ranking # # # # #
Seq. Asset Change 168.21 % - - - -
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




APMD Company Profile • Back to APMD Efficiency Comparisons • Compare APMD Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Assets at quarter ending Jun 30 2026
Regenxbio Inc   0.41 $ 174.482  Millions$ 426.687  Millions
Verastem Inc   0.41 $ 87.526  Millions$ 214.403  Millions
Medtronic Plc  0.41 $ 37,542.000  Millions$ 92,340.000  Millions
Viatris Inc   0.40 $ 14,737.300  Millions$ 36,748.175  Millions
Jazz Pharmaceuticals Plc  0.40 $ 4,601.233  Millions$ 11,489.081  Millions
Rxsight Inc   0.40 $ 127.729  Millions$ 319.260  Millions
Zai Lab Limited  0.40 $ 449.614  Millions$ 1,125.463  Millions
Immunocore Holdings Plc  0.40 $ 430.775  Millions$ 1,090.322  Millions
Quanterix Corporation  0.39 $ 152.716  Millions$ 387.301  Millions
Becton Dickinson And Company  0.39 $ 20,840.000  Millions$ 53,053.250  Millions
Schrodinger Inc   0.39 $ 259.035  Millions$ 663.600  Millions
Butterfly Network Inc   0.39 $ 112.360  Millions$ 288.863  Millions
Bausch and Lomb Corp  0.38 $ 5,324.000  Millions$ 13,873.250  Millions
Biomarin Pharmaceutical Inc  0.38 $ 3,406.614  Millions$ 8,880.837  Millions
Aligos Therapeutics Inc   0.38 $ 31.518  Millions$ 82.296  Millions
Veracyte Inc   0.38 $ 544.735  Millions$ 1,424.143  Millions
Protagonist Therapeutics inc   0.38 $ 281.992  Millions$ 738.220  Millions
Beta Bionics Inc   0.38 $ 119.513  Millions$ 313.898  Millions
Regeneron Pharmaceuticals Inc   0.38 $ 15,534.700  Millions$ 40,831.875  Millions
Novavax inc   0.38 $ 413.796  Millions$ 1,088.785  Millions
Ars Pharmaceuticals Inc   0.38 $ 116.927  Millions$ 309.380  Millions
Arrowhead Pharmaceuticals Inc   0.37 $ 669.495  Millions$ 1,787.717  Millions
Sotera Health Company  0.37 $ 1,215.925  Millions$ 3,248.010  Millions
Elanco Animal Health Incorporated  0.37 $ 5,020.000  Millions$ 13,423.000  Millions
Intelligent Bio Solutions Inc   0.37 $ 4.215  Millions$ 11.273  Millions
Geron Corporation  0.37 $ 204.301  Millions$ 547.763  Millions
Zimmer Biomet Holdings Inc   0.37 $ 8,508.800  Millions$ 23,024.775  Millions
Gossamer Bio Inc   0.36 $ 53.286  Millions$ 146.709  Millions
Aquestive Therapeutics Inc   0.36 $ 54.087  Millions$ 149.303  Millions
Ionis Pharmaceuticals Inc   0.36 $ 1,169.419  Millions$ 3,238.360  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.